Skip to content
healthcare.dev

DAPAGLIFLOZIN

NDC 66993-456, DAPAGLIFLOZIN, tablet, film coated, from Prasco Laboratories.

Product NDC
66993-456
Status
Listed
Labeler
Prasco Laboratories
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA202293
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-456 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN PROPANEDIOL5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
66993-456-306699304563030 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-456-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3aba33aa-f8c6-4b10-85c8-dfa14578d07c
  • NADAC price for package 66993045630

    GET /v1/drugs/nadac/66993045630

Use it

Look up 66993-456 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-456 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-456. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.